Dr. Reddy's Laboratories Ltd. (RDY)
12.49
+0.17
(+1.38%)
USD |
NYSE |
Oct 06, 16:00
12.35
-0.14
(-1.12%)
Pre-Market: 08:42
Dr. Reddy's Laboratories Profit Margin (Quarterly) : 5.39% for None
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.39% |
| March 31, 2026 | 2.93% |
| December 31, 2025 | 13.63% |
| September 30, 2025 | 16.20% |
| June 30, 2025 | 16.50% |
| March 31, 2025 | 18.66% |
| December 31, 2024 | 16.79% |
| September 30, 2024 | 16.73% |
| June 30, 2024 | 18.14% |
| March 31, 2024 | 18.45% |
| December 31, 2023 | 19.11% |
| September 30, 2023 | 21.51% |
| June 30, 2023 | 20.81% |
| March 31, 2023 | 15.23% |
| December 31, 2022 | 18.42% |
| September 30, 2022 | 17.65% |
| June 30, 2022 | 22.77% |
| March 31, 2022 | 1.61% |
| December 31, 2021 | 13.28% |
| September 30, 2021 | 17.21% |
| June 30, 2021 | 11.60% |
| March 31, 2021 | 7.66% |
| December 31, 2020 | 0.40% |
| September 30, 2020 | 15.57% |
| June 30, 2020 | 13.11% |
| Date | Value |
|---|---|
| March 31, 2020 | 17.24% |
| December 31, 2019 | -13.00% |
| September 30, 2019 | 22.76% |
| June 30, 2019 | 17.24% |
| March 31, 2019 | 10.82% |
| December 31, 2018 | 12.60% |
| September 30, 2018 | 13.27% |
| June 30, 2018 | 12.26% |
| March 31, 2018 | 8.55% |
| December 31, 2017 | 8.79% |
| September 30, 2017 | 8.03% |
| June 30, 2017 | 1.78% |
| March 31, 2017 | 8.79% |
| December 31, 2016 | 12.68% |
| September 30, 2016 | 8.23% |
| June 30, 2016 | 3.90% |
| March 31, 2016 | 1.99% |
| December 31, 2015 | 14.60% |
| September 30, 2015 | 18.10% |
| June 30, 2015 | 16.65% |
| March 31, 2015 | 13.41% |
| December 31, 2014 | 14.95% |
| September 30, 2014 | 16.00% |
| June 30, 2014 | 15.65% |
| March 31, 2014 | 13.84% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 9.28% |
| Teva Pharmaceutical Industries Ltd. | -13.88% |
| Novo Nordisk A/S | 26.74% |
| AstraZeneca PLC | 20.15% |
| ANI Pharmaceuticals, Inc. | 8.65% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.96% |
| Return on Assets | 5.99% |
| Return on Invested Capital | 7.63% |
| Gross Profit Margin (Quarterly) | 42.70% |
| Operating Margin (Quarterly) | 3.76% |
| Return on Net Operating Assets | 8.20% |